Nitrofurantoin Dosing for Uncomplicated UTI
For an uncomplicated lower urinary tract infection in a non-pregnant adult with normal renal function, prescribe nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for 5 days. 1
Standard Dosing Regimen
Nitrofurantoin monohydrate/macrocrystals (Macrobid) 100 mg twice daily for 5 days is the recommended first-line regimen endorsed by the Infectious Diseases Society of America (IDSA), European Society for Microbiology and Infectious Diseases (ESCMID), and European Association of Urology. 1, 2
This 5-day regimen achieves clinical cure rates of 88–93% and bacteriological cure rates of 81–92% in women with uncomplicated cystitis. 1
The 5-day duration represents the optimal balance between efficacy and minimizing antibiotic exposure; extending therapy beyond 5–7 days provides no additional benefit and increases adverse event risk. 1, 2
Alternative Nitrofurantoin Formulations
Nitrofurantoin macrocrystals 50–100 mg four times daily for 5 days is an acceptable alternative formulation. 1
For vancomycin-resistant Enterococcus (VRE) uncomplicated UTIs specifically, a dose of 100 mg four times daily may be used. 1
Efficacy Compared to Other First-Line Agents
Nitrofurantoin 100 mg twice daily for 5 days demonstrates superior clinical and microbiological efficacy compared to single-dose fosfomycin 3 g (70% vs 58% clinical resolution at 28 days; 74% vs 63% microbiological cure). 3
The 5-day nitrofurantoin regimen is equivalent to trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days in clinical and microbiological cure rates. 1
Nitrofurantoin has similar clinical cure rates to ciprofloxacin when comparing 7-day regimens, but is preferred due to minimal resistance development and lower collateral damage to normal flora. 1
Critical Contraindications and Safety Precautions
Renal Function Requirements
Always verify creatinine clearance before prescribing—this is the most common and dangerous prescribing error. 2
Nitrofurantoin is absolutely contraindicated when creatinine clearance is <30 mL/min due to inadequate urinary drug concentrations and markedly increased risk of peripheral neuropathy, pulmonary toxicity, and hepatotoxicity. 1, 4
The American Geriatrics Society specifically warns against use in older adults with CrCl <30 mL/min due to heightened risk of irreversible peripheral neuropathy. 1
Upper Tract Infection Exclusion
Do not prescribe nitrofurantoin if pyelonephritis is suspected or confirmed—the drug does not achieve adequate renal tissue concentrations. 1
Red flags for upper tract involvement include: fever >38°C, flank pain, costovertebral angle tenderness, nausea/vomiting, or systemic symptoms. 1
For any "borderline" upper tract symptoms (even mild flank pain or low-grade fever), nitrofurantoin is ineffective and a fluoroquinolone or cephalosporin must be used instead. 1
Common Adverse Effects
Nausea and headache are the most frequently reported side effects, occurring in 5.6–34% of patients. 1, 2
These gastrointestinal effects are dose-related and can be minimized by taking the medication with food. 4
Serious pulmonary reactions (chronic interstitial pneumonitis/fibrosis) occur primarily with continuous treatment for ≥6 months; acute pulmonary reactions typically occur within the first week and are reversible with cessation. 4
Peripheral neuropathy may become severe or irreversible, particularly in patients with renal impairment, anemia, diabetes, electrolyte imbalance, or vitamin B deficiency. 4
Follow-Up Recommendations
Routine post-treatment urine cultures are NOT indicated for asymptomatic patients. 1, 2
Obtain urine culture with susceptibility testing only if symptoms do not resolve by end of treatment or recur within 2 weeks. 1, 2
If retreatment is needed, assume the organism is not susceptible to nitrofurantoin and use a different antibiotic for 7 days. 2
Special Populations
Men with Uncomplicated UTI
For men with uncomplicated UTI, prescribe 100 mg twice daily for 7 days (longer duration than women) based on limited observational data. 2
Always consider the possibility of prostatitis in men with UTI symptoms, as nitrofurantoin does not penetrate prostatic tissue adequately. 1
Pediatric Dosing
Key Clinical Pitfalls to Avoid
Never prescribe without checking renal function—this is the single most dangerous error. 2
Do not use for complicated UTIs (structural/functional abnormalities, obstruction, instrumentation, pregnancy). 1
Do not use in men with suspected prostatitis—inadequate prostatic tissue penetration. 1
Do not extend treatment beyond 7 days unless symptoms persist, as longer courses increase toxicity without improving efficacy. 1
Avoid in patients with any suspicion of upper tract involvement—even mild flank pain warrants alternative therapy. 1